|
Name |
Koaburaside
|
Molecular Formula | C14H20O9 | |
IUPAC Name* |
(2S,3R,4S,5S,6R)-2-(4-hydroxy-3,5-dimethoxyphenoxy)-6-(hydroxymethyl)oxane-3,4,5-triol
|
|
SMILES |
COC1=CC(=CC(=C1O)OC)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O
|
|
InChI |
InChI=1S/C14H20O9/c1-20-7-3-6(4-8(21-2)10(7)16)22-14-13(19)12(18)11(17)9(5-15)23-14/h3-4,9,11-19H,5H2,1-2H3/t9-,11-,12+,13-,14-/m1/s1
|
|
InChIKey |
SWHCKWOYUSDWOF-RGCYKPLRSA-N
|
|
Synonyms |
Koaburaside; 41653-73-0; (2S,3R,4S,5S,6R)-2-(4-hydroxy-3,5-dimethoxyphenoxy)-6-(hydroxymethyl)oxane-3,4,5-triol; J8R952KQV3; beta-D-Glucopyranoside, 4-hydroxy-3,5-dimethoxyphenyl; (2S,3R,4S,5S,6R)-2-(4-Hydroxy-3,5-dimethoxyphenoxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol; UNII-J8R952KQV3; 4-Hydroxy-3,5-dimethoxyphenyl Beta-D-glucopyranoside; CHEMBL513117; DTXSID301045650; ZINC33832141; AKOS032962323; Q15426244; (-)-3,5-Dimethoxy-4-hydroxyphenyl beta-D-glucopyranoside; 3,5-dimethoxy-4-hydroxyphenol-1-O-beta-d-glucopyranoside; 4-HYDROXY-3,5-DIMETHOXYPHENYL .BETA.-D-GLUCOPYRANOSIDE; (-)-3,5-DIMETHOXY-4-HYDROXYPHENYL .BETA.-D-GLUCOPYRANOSIDE
|
|
CAS | 41653-73-0 | |
PubChem CID | 5318820 | |
ChEMBL ID | CHEMBL513117 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 332.3 | ALogp: | -0.9 |
HBD: | 5 | HBA: | 9 |
Rotatable Bonds: | 5 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 138.0 | Aromatic Rings: | 2 |
Heavy Atoms: | 23 | QED Weighted: | 0.465 |
Caco-2 Permeability: | -6.106 | MDCK Permeability: | 0.00005780 |
Pgp-inhibitor: | 0.003 | Pgp-substrate: | 0.274 |
Human Intestinal Absorption (HIA): | 0.719 | 20% Bioavailability (F20%): | 0.005 |
30% Bioavailability (F30%): | 0.809 |
Blood-Brain-Barrier Penetration (BBB): | 0.449 | Plasma Protein Binding (PPB): | 44.27% |
Volume Distribution (VD): | 0.505 | Fu: | 27.40% |
CYP1A2-inhibitor: | 0.04 | CYP1A2-substrate: | 0.589 |
CYP2C19-inhibitor: | 0.012 | CYP2C19-substrate: | 0.808 |
CYP2C9-inhibitor: | 0.001 | CYP2C9-substrate: | 0.308 |
CYP2D6-inhibitor: | 0.011 | CYP2D6-substrate: | 0.365 |
CYP3A4-inhibitor: | 0.004 | CYP3A4-substrate: | 0.033 |
Clearance (CL): | 4.384 | Half-life (T1/2): | 0.898 |
hERG Blockers: | 0.171 | Human Hepatotoxicity (H-HT): | 0.179 |
Drug-inuced Liver Injury (DILI): | 0.043 | AMES Toxicity: | 0.172 |
Rat Oral Acute Toxicity: | 0.008 | Maximum Recommended Daily Dose: | 0.008 |
Skin Sensitization: | 0.7 | Carcinogencity: | 0.1 |
Eye Corrosion: | 0.011 | Eye Irritation: | 0.118 |
Respiratory Toxicity: | 0.045 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC004076 | 0.671 | D06BQU | 0.463 | ||||
ENC002201 | 0.505 | D0H3KI | 0.388 | ||||
ENC004909 | 0.488 | D0TC7C | 0.370 | ||||
ENC004798 | 0.488 | D0I9HF | 0.364 | ||||
ENC005772 | 0.475 | D01TNW | 0.333 | ||||
ENC004797 | 0.471 | D0H2RI | 0.329 | ||||
ENC003813 | 0.469 | D07NSU | 0.329 | ||||
ENC003752 | 0.464 | D0T5BC | 0.319 | ||||
ENC004073 | 0.460 | D0B8UJ | 0.319 | ||||
ENC005169 | 0.452 | D05ZYM | 0.312 |